An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies.
Morar-Mitrica S, Adams ML, Crotts G, Wurth C, Ihnat PM, Tabish T, Antochshuk V, DiLuzio W, Dix DB, Fernandez JE, Gupta K, Fleming MS, He B, Kranz JK, Liu D, Narasimhan C, Routhier E, Taylor KD, Truong N, Stokes ESE.
Morar-Mitrica S, et al. Among authors: wurth c.
J Pharm Sci. 2018 Feb;107(2):529-542. doi: 10.1016/j.xphs.2017.10.017. Epub 2017 Oct 23.
J Pharm Sci. 2018.
PMID: 29074375